Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain
retraction
OA: closed
CC0
RETRACTED
⤵ 38 in-corpus citations
Retraction notice. Marked retracted by OpenAlex; see publisher for the formal retraction notice.
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- A comparison of nafarelin acetate and danazol in the treatment of endometriosis via openalex
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. via openalex
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis via openalex
- Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex
- Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- Megestrol acetate for treatment of endometriosis. via openalex
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
- REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN via openalex
- Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy via openalex
- The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- The reproducibility of the revised American Fertility Society classification of endometriosis via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. via openalex
- W6717624033 via openalex
- W1988605646 via openalex
- W1998117916 via openalex
- W2062982521 via openalex
- W2084292307 via openalex
- W2287757320 via openalex
- W2407038112 via openalex
- W2417044776 via openalex
- W2477008945 via openalex
- W6600720097 via openalex
- W6607058909 via openalex
- W6607068977 via openalex
- W6655287665 via openalex
- W6666412496 via openalex
- W6714902491 via openalex
Cited by (38)
- Endometriosis 2021
- Endometriosis in Adolescent Girls 2020
- Postoperative Hormonal Suppression for Prevention of Deeply Infiltrative Endometriosis Recurrence After Surgery 2018
- Endometriosis after menopause: physiopathology and management of an uncommon condition 2017
- Optimal uterine anatomy and physiology necessary for normal implantation and placentation 2016
- Adenomiosis: tratamiento 2015
- Comparison of complete and incomplete excision of deep infiltrating endometriosis. 2015
- Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density 2014
- Quality of life according to add-back therapy during GnRH agonist treatment in endometriosis patients 2012
- Endometriosis 2012
- Traitement de l'adénomyose 2007
- Tratamiento de la adenomiosis 2007
- Endometriosis 2007
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain 2006
- Neumotórax catamenial asociado a endometriosis pelviana: a propósito de un caso 2005
- Add-back therapy in the treatment of endometriosis-associated pain 2004
- Extraperitoneal endometriosis with catamenial pneumothoraces: a review of the literature. 2004
- Current and Potential Application of GnRH Agonists in Gynecologic Practice 2000
- 10.1016/s0246-1064(14)65366-4 2000
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up 2000
- 10.1016/s0246-1064(19)30222-1 2000
- Medical Treatment of Endometriosis 1999
- Effects of Add-Back Therapy on Bone Mineral Density and Pyridinium Crosslinks in Patients with Endometriosis Treated with Gonadotropin-Releasing Hormone Agonists 1999
- Combined Medical and Surgical Treatment of Women with Endometriosis 1999
- Current Drug Therapy Recommendations for the Treatment of Endometriosis 1999
- Endometriosis and Pelvic Pain 1998
- Steroidal ‘Add-Back’ Therapy in Patients Treated with GnRH Agonists 1998
- MODERN MEDICAL MANAGEMENT OF ENDOMETRIOSIS 1997
- A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone 1997
- Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis 1997
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment 1996
- Endometriosis: An Enigmatic Disease 1996
- Endometriosis 1996
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. 1996
- Endocrine effects of GnRH analogue with low‐dose hormone replacement therapy in women with endometriosis 1995
- Pain recurrence: A quality of life issue in endometriosis 1995
- Pros and Cons of “Add-back” Therapy 1994
- Leuprorelin 1994
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:34.315996+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK